Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

TRANSPARENCY-RX CORP.

Filed by ARENTFOX SCHIFF LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
6a5a220f-9861-4034-b550-3694917f1624
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Pharmacy Benefit Manager Reform Transparency in prescription drug markets Prescription drug prices S. 891 (Bipartisan Health Care Act), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices H.R. 4317 (PBM Reform Act of 2025), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices

Literal federal measure citations: S. 891, H.R. 4317

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.